Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia

Eva Ferreras, Elizabeth Chizema-Kawesha(Ministry of Health), Alexandre Blake, Orbrie Chewe(Ministry of Health), John Mwaba(University Teaching Hospital), Gideon Zulu(Ministry of Health), Marc Poncin(Médecins Sans Frontières), Ankur Rakesh, Anne‐Laure Page, Savina Stoitsova(European Centre for Disease Prevention and Control), Caroline Voute(Médecins Sans Frontières), Florent Uzzeni(Médecins Sans Frontières), Hugues Robert(Médecins Sans Frontières), Micaela Serafini(Médecins Sans Frontières), Belem Matapo(World Health Organization - Zambia), Jose-María Eiros(Universidad de Valladolid), Marie-Laure Quilici(Institut Pasteur), Lorenzo Pezzoli(World Health Organization), Andrew S. Azman(Johns Hopkins University), Sandra Cohuet, Iza Ciglenečki(Médecins Sans Frontières), Kennedy Malama(Ministry of Health), Francisco J. Luquero
New England Journal of Medicine
February 7, 2018
Cited by 80Open Access
Full Text

Abstract

To the Editor: Killed oral cholera vaccines (OCVs) are part of the standard response package to a cholera outbreak, although the two-dose regimen of vaccines that has been prequalified by the World Health Organization (WHO) poses challenges to timely and efficient reactive vaccination campaigns. ] An emergency reactive vaccination campaign was implemented in April 2016, targeting more than 500,000 persons who were at high risk for cholera in Lusaka (population, >2 million persons). The Ministry of Health, with support from Mdecins sans Frontires and the WHO, decided to implement a single-dose campaign to quell the epidemic rapidly, in view of the insufficient number of vaccine doses that were available in the global stockpile to complete a two-dose campaign. In December 2016, when more doses became available, a second round of vaccination was organized and the second vaccine dose was offered to persons at risk.


Related Papers

No related papers found

Powered by citation graph analysis